Table 2.
Results of conditional logistic regression analysis of the relationship between current use of inhaled corticosteroids and use of antidiabetics (n = 16 425).
| Rate ratio | 95% confidence interval | |
|---|---|---|
| Crude model | ||
| IC* use | ||
| Non-user | 1.0 | – |
| Any IC use | 1.4 | 1.2, 1.5 |
| Adjusted model | ||
| IC use | ||
| Non-user | 1.0 | – |
| Any IC use | 0.9 | 0.8, 1.1 |
| Oral corticosteroids | ||
| No | 1.0 | |
| Yes | 2.9 | 2.5, 3.3 |
| Age (years) | ||
| 65–74.9 | 1.0 | – |
| 75–84.9 | 0.8 | 0.7, 0.9 |
| >85 | 0.7 | 0.5, 0.9 |
| Gender | ||
| Male | 1.0 | |
| Female | 1.3 | 1.2, 1.5 |
| Number of concurrent prescriptions | ||
| 0 | 1.0 | |
| >1 | 2.2 | 1.9, 2.5 |
| Physician visits | ||
| 0–24 | 1.0 | |
| 25–48 | 1.2 | 1.0, 1.5 |
| >48 | 1.5 | 1.2, 1.8 |
| Hospitalizations | ||
| 0 | 1.0 | |
| 1–3 | 1.3 | 1.0, 1.6 |
| >3 | 1.6 | 1.3, 2.1 |
*
Inhaled corticosteroid.